Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Date publication

août 2022

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ROUSSEL Xavier

Tous les auteurs :
Averbuch D, De Greef J, Duréault A, Wendel L, Tridello G, Lebeaux D, Mikulska M, Gil L, Knelange N, Zuckerman T, Roussel X, Robin C, Xhaard A, Aljurf M, Beguin Y, Le Bourgeois A, Botella-Garcia C, Khanna N, Van Praet J, Kröger N, Blijlevens N, Ducastelle Leprêtre S, Ho A, Roos-Weil D, Yeshurun M, Lortholary O, Fontanet A, de la Camara R, Coussement J, Maertens J, Styczynski J,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34596213

Résumé

Nocardiosis is rare after hematopoietic cell transplantation (HCT). Little is known regarding its presentation, management, and outcome in this population.

Mots clés

central nervous system infection, hematopoietic cell transplantation, mortality, nocardiosis

Référence

Clin Infect Dis. 2022 08 24;75(1):88-97